Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
0.0%
operating margin TTM
0.0%
revenue TTM
5.71 Million
revenue per share TTM
0.27$
valuation ratios | |
|---|---|
| pe ratio | -22.14 |
| peg ratio | 4.92 |
| price to book ratio | 7.65 |
| price to sales ratio | 0.00 |
| enterprise value multiple | -21.26 |
| price fair value | 7.65 |
profitability ratios | |
|---|---|
| gross profit margin | 0.0% |
| operating profit margin | 0.0% |
| pretax profit margin | 0.0% |
| net profit margin | 0.0% |
| return on assets | -32.33% |
| return on equity | -58.74% |
| return on capital employed | -37.15% |
liquidity ratios | |
|---|---|
| current ratio | 10.22 |
| quick ratio | 10.22 |
| cash ratio | 5.98 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 47.40 |
| cash conversion cycle | -47.40 |
| receivables turnover | 0.00 |
| payables turnover | 7.70 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.00 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -2,267.08 |
cash flow ratios | |
|---|---|
| free cash flow per share | -11.09 |
| cash per share | 26.63 |
| operating cash flow per share | -11.08 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -2,267.08 |
| short term coverage ratios | -2,267.08 |
| capital expenditure coverage ratio | -2,078.16 |
Frequently Asked Questions
When was the last time Praxis Precision Medicines, Inc. (NASDAQ:PRAX) reported earnings?
Praxis Precision Medicines, Inc. (PRAX) published its most recent earnings results on 05-11-2025.
What is Praxis Precision Medicines, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Praxis Precision Medicines, Inc. (NASDAQ:PRAX)'s trailing twelve months ROE is -58.74%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Praxis Precision Medicines, Inc. (PRAX) currently has a ROA of -32.33%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did PRAX's net profit margin stand at?
PRAX reported a profit margin of 0.0% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is PRAX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 10.22 in the most recent quarter. The quick ratio stood at 10.22, with a Debt/Eq ratio of 0.00.